Weiss Asset Management LP lessened its stake in Avantor, Inc. (NYSE:AVTR – Free Report) by 30.1% in the first quarter, HoldingsChannel.com reports. The firm owned 527,903 shares of the company’s stock after selling 227,493 shares during the quarter. Weiss Asset Management LP’s holdings in Avantor were worth $4,139,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently added to or reduced their stakes in AVTR. Caxton Associates LLP acquired a new position in Avantor during the first quarter worth about $79,000. Sei Investments Co. lifted its position in shares of Avantor by 0.9% during the 1st quarter. Sei Investments Co. now owns 5,287,850 shares of the company’s stock valued at $41,457,000 after acquiring an additional 46,707 shares during the period. State of Wyoming lifted its position in shares of Avantor by 473.0% during the 1st quarter. State of Wyoming now owns 34,905 shares of the company’s stock valued at $274,000 after acquiring an additional 28,813 shares during the period. Cetera Investment Advisers boosted its stake in shares of Avantor by 34.1% during the 1st quarter. Cetera Investment Advisers now owns 38,569 shares of the company’s stock worth $302,000 after acquiring an additional 9,799 shares in the last quarter. Finally, PNC Financial Services Group Inc. boosted its stake in shares of Avantor by 83.7% during the 1st quarter. PNC Financial Services Group Inc. now owns 47,157 shares of the company’s stock worth $370,000 after acquiring an additional 21,481 shares in the last quarter. Hedge funds and other institutional investors own 95.08% of the company’s stock.
Insiders Place Their Bets
In related news, Director Simon Dingemans acquired 25,000 shares of Avantor stock in a transaction dated Friday, May 1st. The shares were acquired at an average cost of $8.14 per share, for a total transaction of $203,500.00. Following the completion of the transaction, the director directly owned 25,000 shares of the company’s stock, valued at $203,500. The trade was a ∞ increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Gregory T. Lucier acquired 10,000 shares of Avantor stock in a transaction dated Friday, May 8th. The stock was bought at an average price of $8.32 per share, for a total transaction of $83,200.00. Following the completion of the transaction, the director directly owned 60,000 shares of the company’s stock, valued at approximately $499,200. This represents a 20.00% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders own 0.28% of the company’s stock.
Wall Street Analysts Forecast Growth
Get Our Latest Stock Analysis on AVTR
Avantor Trading Up 0.2%
Shares of AVTR opened at $11.47 on Monday. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.17. Avantor, Inc. has a 1-year low of $7.26 and a 1-year high of $15.93. The stock has a market cap of $7.83 billion, a price-to-earnings ratio of -14.16, a price-to-earnings-growth ratio of 6.37 and a beta of 0.94. The firm has a 50 day simple moving average of $9.71 and a 200-day simple moving average of $9.40.
Avantor (NYSE:AVTR – Get Free Report) last posted its earnings results on Wednesday, April 29th. The company reported $0.17 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.16 by $0.01. The firm had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.54 billion. Avantor had a positive return on equity of 9.95% and a negative net margin of 8.42%.Avantor’s revenue was up .0% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.23 EPS. Equities analysts forecast that Avantor, Inc. will post 0.79 EPS for the current fiscal year.
About Avantor
Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.
Avantor’s offerings are organized across two primary segments.
Featured Stories
- Five stocks we like better than Avantor
- RTX and Lockheed Earnings: Can Strong Guidance Reset the Defense Trade?
- These 4 Earnings Reports Expose the Market’s Growing Economic Divide
- Broadcom May Be the Biggest Winner From Alphabet’s Earnings
- Volatility Is Back and These 3 Market Tollbooths Are Best Positioned to Profit
Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR – Free Report).
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.
